Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 8/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.35 |
| ▸ | F9 | P00740 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24965715 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL24964098 | 0.98 | S1PR5 (0.36) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL24964668 | 0.98 | S1PR5 (0.36) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL24964665 | 0.98 | S1PR5 (0.36) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL24964664 | 0.98 | S1PR5 (0.36) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL24965422 | 0.97 | CA12 (0.35) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL23233355 | 0.96 | CA12 (0.36) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL23233368 | 0.96 | CA12 (0.36) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL24963036 | 0.96 | CA12 (0.36) | CA12CA1CA2CA9S1PR5 | |
| SCHEMBL25137765 | 0.96 | CA12 (0.35) | CA12CA1CA2CA9S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026162-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026162-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | L1CAM, LEF1, MLX | CA12 2532/4885CA1 2484/4885CA2 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.